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Edward B. Breitschwerdt1,2Abstract
Bartonella henselae, a flea-transmitted bacterium, causes chronic, zoonotic, blood stream infections in immunocompetent
and immunocompromised patients throughout the world. As an intra-erythrocytic and endotheliotropic bacterium,
B. henselae causes a spectrum of symptomatology ranging from asymptomatic bacteremia to fever, endocarditis and
death. Veterinary workers are at occupational risk for acquiring bartonellosis. As an emerging, and incompletely
understood, stealth bacterial pathogen, B. henselae may or may not have been responsible for the deaths of two
veterinarians; however, recent evidence indicates that this genus is of much greater medical importance than is
currently appreciated by the majority of the biomedical community.
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deaths of two veterinarians?” will never be definitively
answered; however, after months of asking myself this
question, I decided to comment on the possibility that a
recently discovered stealth bacteria [1] may have played
a role in their deaths. If one were to organize a phys-
ician/scientist review of each patient’s medical record,
examining the voluminous doctors’, nurses’, consultants’
notes and hundreds of laboratory results; if this team
were to visit with wives, family, and friends left behind,
and had access to the test results generated by our re-
search group (see acknowledgements) prior to and after
their respective deaths, I am of the opinion that this ques-
tion could never be accurately or adequately answered.
Perhaps questions for which there are not definitive
answers should never be asked, but if true, there would
be no need for biomedical research. Unfortunately, many
questions remain unanswered, a fact that is very hard for
patients, family members, doctors, and diagnosticians to
accept. Medicine remains “a practice,” based upon the
best available science, the art of patient care, and a clini-
cian’s attempts to manage symptoms and disease processes
for which causation is elusive. Because of circumstancesCorrespondence: ed_breitschwerdt@ncsu.edu
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unless otherwise stated.beyond everyone’s control, involvement of my research la-
boratory team was less than optimal due to the timing of
specimen collection and type of samples available for Bar-
tonella testing.
Voltaire, (1694 to 1778), stated: “Doctors put drugs of
which they know little, into our bodies of which they
know less, to treat diseases of which they know nothing
at all.” Clearly, medical science and 21st century patient
care have advanced tremendously since Voltaire’s time;
however, there are still major gaps in scientific knowledge
that negatively impact patient outcomes. Specifically, our
collective lack of “knowledge” negatively impacts directed
therapy and effective management of the patient’s illness
and deficiencies in medical knowledge related to the genus
Bartonella continue to compromise patient care through-
out the world.
It is my hope that this commentary will benefit future
patients, particularly veterinary workers, who have been
or will become infected with the emerging and incom-
pletely understood, stealth bacterial pathogen; Bartonella
henselae. The term “emerging infectious disease” has been
abused and to an extent overused in recent years, often in
association with efforts to influence the appropriation of
research funding. During the past two decades, bartonello-
sis has clearly earned the designation “an emerging infec-
tious disease.” The genus Bartonella has expanded from
two known species prior to 1992 to at least 34 Bartonella
species in 2015. Medically, fifteen Bartonella species havel. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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fore, incompletely understood is another way to accurately
describe this genus. The fascinating history of Bartonella
has been summarized in recent reviews [2–4]; whereas the
contemporary history of this genus is being written and
rewritten as new knowledge is generated around the
world. The past and more recent history of bartonellosis
[1–4] is beyond the scope of this commentary. However, a
brief historical perspective is necessary to put the lives and
deaths of these veterinarians into context. Prior to the rec-
ognition that bacillary angiomatosis and peliosis hepatis
were caused by Bartonella quintana or B. henselae in
AIDS patients [5, 6], bartonellosis was not a differential
diagnosis for sick humans or other animals throughout
most of the world [1, 3]. Prior to the AIDS epidemic, indi-
genous infection with a Bartonella sp. had never been di-
agnosed by a physician or veterinarian in North America.
Not surprisingly, clinicians cannot diagnose an as yet “un-
known or undiscovered” infectious agent. Importantly, the
history of Bartonella spp. infections substantially pre-dates
AIDS. Bartonella bacilliformis, transmitted by sandflies,
caused Oroya Fever and verruga peruana in indigenous
Peruvian Indians hundreds of years ago; infected Spanish
conquistadors, and caused highly fatal illness in immigrant
workers building the Trans Peruvian railroad [2–4]. Pur-
portedly, one worker died of hemolytic anemia (Oroya
Fever) for each railroad tie that was laid. A second Barto-
nella species, B. quintana, transmitted by the human body
louse, was a major cause of morbidity and mortality dur-
ing the World Wars [2–4], and continues to cause human
suffering and death among a spectrum of people (urban
trench fever), particularly individuals experiencing human
body louse exposure in association with wars and famine,
or those living in poverty and abusing drugs in modern
day cities. Since the “rediscovery” of Bartonella species in-
fections in AIDS patients, numerous new species have
been implicated as a cause of illnesses in immunocom-
promised and immunocompetent patients [2, 7, 8]. Des-
pite a dramatic expansion of medical and microbiological
knowledge related to the genus Bartonella [1, 3, 6], there
are still major knowledge gaps involving clinically relevant
questions.
Findings
Due to their lengthy illnesses, frequent medical evalua-
tions, and involvement of numerous medical specialists
and medical centers throughout the United States, only
a brief, superficial overview of each veterinarian’s illness
is possible. As an example of the medical complexity,
veterinarian #1 was transferred among six different hos-
pitals during the last 5 months of his life (October 2012
through February 2012). Selected historical and demo-
graphic information is summarized (Table 1). When I
entered the University of Georgia, College of VeterinaryMedicine in 1970, Veterinarian #1 was a professor. I will
always remember him as a caring, enthusiastic, outgoing
and intelligent teacher. Before I graduated, he left the
University and started a companion animal veterinary
practice, where he worked for the remainder of his car-
eer. On April 11th, 2011, I received this email communi-
cation from him: “Ed. 15 years ago, my cardiologist told
me I was in an "elite group" of individuals as pertaining
to cardiovascular fitness. Last week, we discovered I
need a mitral, aortic and tricuspid valve replacement to
be done this Friday. Remembering some of your articles,
I believe you stated that the number 1 cause of culture-
negative endocarditis in humans was bartonellosis. I
have been hospitalized twice in the last 2 years for severe
pneumonia. Do you think that is something I should
check on and if so, what samples could I send to you to
attempt culture or PCR. I hate to impose on you like
this, but my cardiologist does not give it much weight
nor does my family practitioner. Hope all is well with
you and family.”
Although our paths had crossed occasionally during
the ensuing 38 years, this email request initiated his
entry into our Institutional Review Board approved re-
search study (North Carolina State University, 164-08-
05). This man was in good health until June 2010, when
he lost consciousness, fell and was diagnosed with pneu-
monia. In April 2011, he had mitral valve replacement
surgery, closure of a patent foramen ovale, 2-vessel by-
pass, bilateral maze procedure, radio frequency ablation,
ligation of the left atrial appendage and pacemaker
placement. Based upon self-reporting in a standardized
questionnaire completed by all participants in our IRB-
approved study, progressive symptoms including fatigue,
disorientation, blurred vision, balance problems, diffi-
culty remembering, eye pain, insomnia, muscle weak-
ness, loss of sensation or numbness in the legs, and
shortness of breath developed postoperatively in 2011.
These non-specific symptoms are often reported by vet-
erinary workers infected with one or co-infected with
more than one Bartonella sp. [9–14]. Veterinarians, veter-
inary technicians, animal handlers, and groomers appear
to be occupationally at risk groups for Bartonella spp.
infections [9, 10]. Because of their frequent exposure to
arthropod-infested, Bartonella spp. bacteremic animals,
we have suggested that veterinary workers represent a sen-
tinel, research study population for clarifying the medical
importance of the genus Bartonella [15, 16]. From the
context of research priorities and research funding, this
suggestion has been ignored by policy makers and govern-
mental agencies in the United States.
Relapsing fever of unknown origin (FUO) with tempera-
tures as high as 104 °F, developed in October 2011
(6 months after surgery). Despite various antibiotic therap-
ies, febrile episodes, accompanied by periodic dizziness
Table 1 Historical and demographic findings extracted from the study questionnaire provided by the two veterinarians infected
with Bartonella henselae





Number of children Daughter 2 Sons
Employment Status Full-time employed Full-time employed
Occupation Veterinarian Veterinarian
Length of time at current position 44 years 37 years
Medical coverage Yes Yes
Have you been diagnosed with infectious disease Yes- pneumonia Yes - childhood diseases, influenza
Have you been diagnosed with a chronic illness Yes- approximately 2 years duration Yes – mild colitis, gastric reflux
Allergies Yes – Environmental Yes – mild seasonal rhinitis
Has experienced persistent illness Yes No
Self-described health Infrequently ill Healthy
History of symptoms:
Fatigue Yes No
Difficulty remembering Yes No
Disoriented (confused by time or place) Yes No
Eye Pain Yes No
Difficulty sleeping (insomnia) Yes No
Chronic fatigue Yes No
Bladder dysfunction Yes No
Fever Yes No
Mental confusion (disordered thoughts) Yes No
Blurred vision Yes No
Balance problems Yes No
Shortness of breath Yes No
Muscle weakness Loss of sensation or numbness in legs Legs – weak left lower leg since ICE chemotherapy –
symptoms almost gone
Ability to perform the same activities of daily
living prior to illness?
No Yes, until medical leave began July 2012
Ability to perform same employment/school
activities prior to illness?
No Yes, until medical leave began July 2012
Self-reported signs of symptoms Waxing/waning Improving – with current cancer treatment
History of Physician evaluations:




Internal Medicine Yes Yes
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Heart Disease Self + 2 Brothers Father
Cancer Sister – Mammary, Brother – Squamous
Cell Carcinoma
Mother – Colon Cancer
Hypertension Self + 2 Brothers Father + Mother
Asthma Self + Brother
Stroke Father Mother
Substance Abuse Brother
Allergies Self + Mother Self
Diabetes Father
Animal contact:
Dog Yes – Indoor/Outdoor Yes – Indoor/Outdoor
Cat Yes – Indoor/Outdoor Yes – Indoor/Outdoor
Bird Yes – Indoor Yes – Indoor
Horse Yes Yes – Outdoor
Rodent Yes Yes, Hampster – Indoor
Reptile No Yes – Indoor
Fish No Yes
Ferret No Yes
Age of Exposure 0-60+ 0-60+
Allow pets to sleep in same bed as owner Yes Yes – cats only
Allow pets to lick hands, face, feet, etc. Yes Yes
Frequent exposure (>1 time per month) to other
animals
Yes – Dog, Cat Yes – Dog, Cats for 29 years.
Length of exposure to other animals >10 years No
Exposure to production animals No First 8 years post-graduation, treated farm animals
Animal bites or scratches
Dog Yes – since 1960 No
Cat Yes – since 1970 Yes – since 1975
Bird No Yes – 1980
Horse No Yes – 1975
Reptile No Yes – 1980
Rabbit No Yes – 1975
Rodent No Yes – 1980
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Table 1 Historical and demographic findings extracted from the study questionnaire provided by the two veterinarians infected
with Bartonella henselae (Continued)
Outdoor exposure at least once a year Wildlife rescue/rehabilitation, Gardening Hiking, Hunting, Gardening, Cycling, Outdoor water sports
Antibiotics last 12 months:
Ciprofloxacin Current No





Corticosteroids in past 12 months: Yes Yes
Medrol Pak 12/11/2011-12/26/2011 No
Flonase 6/2011-current No
Oral Prednisone No Yes
IV Prednisone No Yes
IV Dexamethasone No Yes






Aspirin 81 mg 1990-current No
Modafinil 2010-current No
Enalipril No Yes
Rosuvastatin calcium No Yes
Oral Antiviral No Yes








Travel outside of state of residence
Northwest US Yes Yes
Northeast US Yes Yes
Southwest US Yes Yes
Southeast US Yes Yes
Animal Contact during Travel Within US
Northwest US Yes No
Northeast US Yes No
Southwest US Yes Yes
Southeast US Yes No
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Table 1 Historical and demographic findings extracted from the study questionnaire provided by the two veterinarians infected
with Bartonella henselae (Continued)
Non continental US & International Travel
Alaska Yes Yes
Mexico Yes Yes
Central America Yes Yes
Carribean Yes Yes
Canada Yes Yes
Australia/New Zealand/Fiji No Yes
Europe No Yes




Central America Yes No
Carribean Yes No
Canada No No
Pet Travel No No
Specialist Doctor Visits:
Chronic mild colitis No Yes
T Cell Lymphoma No Yes
Hyperlipidemia No Duration 15 years – under control with statin
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his death on February 24, 2013. Bartonella spp. are a cause
of FUO and culture-negative endocarditis [17–20]. As
reviewed by Chomel, et al. [17], the first description of hu-
man Bartonella endocarditis was published in 1993. Sub-
sequently, Bartonella endocarditis was reported in cats,
cows, dogs and sea otters [17].
Microbiological improvements in Bartonella sp. isola-
tion methods and PCR amplification of organism-specific
DNA sequences from surgically removed or autopsy ob-
tained heart valves have resulted in the identification of
Bartonella endocarditis cases throughout the world [17,
18]. Between January 23rd and January 30th, 2012, multiple
blood cultures were obtained after consultation with an
infectious diseases physician, of which a subset was sent to
our laboratory for Bartonella testing. FUO had persisted
despite prior treatment with cefixime and concurrent
administration of doxycycline and ciprofloxacin. When
Mycobacterium interjectum grew in one blood culture
processed by a commercial laboratory, the patient was
treated with doxycycline and clarithromycin beginning in
March 2012, followed by clofazimine and clarithromycin.
Mycobacterium interjectum, a slow growing mycobacteria
most often associated with immunosuppression, generally
responds to antibiotic treatment. Bartonella henselae (SA2
genotype) was amplified and sequenced from one of three
blood specimens submitted to our laboratory (Table 2). In
September 2012, the patient’s fever pattern worsened withtemperatures spiking to 105 °F, 2-3 times/week. Due to the
poor response to antibiotics, an extensive workup was per-
formed. Bone marrow and liver biopsies contained granu-
lomatous inflammation, which occurs in association with
Bartonella, Mycobacterium and other intracellular patho-
gens. Bronchoscopic lavage culture grew M. interjectum
and Eikenella corrodens, after which treatment consisted
of tigecycline and prednisolone (60 mg daily), which he
had been taking for most of the previous year for potential
sarcoidosis. In January 2013, the patient was admitted to
National Jewish Health, for evaluation of severe muscular
weakness, dyspnea on exertion, memory loss and fever of
unknown origin. During the diagnostic evaluations the pa-
tient’s condition deteriorated resulting in transfer to the
University of Colorado in Denver. After flying home to
Florida, the patient was hospitalized at Bayfront Medical
Center, after which he was transferred to Shands Hospital,
University of Florida. On February 13th, 2013, after 13 hours
of surgery for vegetative valvular endocarditis, valve re-
placement surgery, splenectomy, and pacemaker removal
the patient never regained consciousness. The death
certificate listed multi-organ failure, sepsis, and myco-
bacterial endocarditis as the cause of death. Nearly two
years after his death, B. henselae with sequence identity of
527/527 bp with B. henselae Fizz, (Gen Bank accession
number AF369526) was amplified and sequenced from a
paraffin-embedded bone marrow specimen obtained in
January 2012. The same B. henselae Fizz genotype
Table 2 Bartonella spp. serology and PCR results from blood, serum, BAPGM enrichment blood culture and subculture agar plate
swab or tissues from each of the two veterinarians









Bvb I Bvb II Bvb III BhHI BhSA2 Bk
#1 1/9/2012 FFPE Bone Marrow Bh Fizz N/A N/A
1/23/2012 Serum Neg <16 <16 <16 <16 <16 <16
Blood Neg Neg 7, 14 Neg
1/28/2012 Serum Bh SA2
Blood Neg Neg 7, 14 Neg
1/30/2012 Serum Neg
Blood Neg Neg 7, 14 Neg
4/11/2012 Serum Neg <16 <16 <16 <16 <16 <16
Blood Neg Neg 14 Neg
4/13/2012 Serum Neg
Blood Neg Neg 14 Neg
4/16/2012 Serum Neg
Blood Neg Neg 14
2/13/2013 FFPE Mitral Valve
Prosthesis
Bh Fizz N/A N/A
#2 2/24/2011 FFPE (LN supraclavicular) Neg N/A N/A
7/25/2012 FFPE (cervical LN) Bh SA2 N/A N/A
4/5/2013 Serum Neg N/A N/A
Blood Neg Neg 7, 14 Neg <16 <16 <16 <16 <16 <16
4/6/2013 Serum Neg
Blood Neg Neg 7, 14 Neg
4/6/2013 Serum Neg
Blood Neg Neg 7, 14 Neg
4/8/2013 Serum Neg
Blood Neg Neg 7, 14 Neg
unknown FFPE bone marrow Neg N/A N/A
N/A- Test not applicable for the sample tested
FFPE- Formalin-fixed paraffin-embedded
Bh- Bartonella henselae, genotypes SA2 or Fizz
Breitschwerdt Parasites & Vectors  (2015) 8:317 Page 7 of 11(identity 527/527 bp) was independently amplified and
sequenced from the mitral valve prosthesis removed
February 13, 2013, just prior to his death. Based upon
blood and tissue PCR amplification and DNA sequen-
cing results, this veterinarian was infected with two B.
henselae genotypes in January 2012 and the Fizz geno-
type persisted at the time of his death. When and how
these infections were acquired, how long the infections
persisted, and if B. henselae contributed to his illness,
FUO and ultimately his death will never be known.
I have been a veterinary internist at North Carolina
State University, College of Veterinary Medicine since
1982. As such, I consult with regional veterinarians on a
near daily basis. Despite the fact that Veterinarian #2 prac-
ticed medicine in North Carolina for 37 years, I did not
know him personally; however, as fate would have it, helived in a house along the North Carolina coast adjacent
to a close friend who was familiar with our Bartonella re-
search. Thus, it was a mutual friend who suggested Barto-
nella testing. Veterinarian #2 developed lymphadenopathy
involving the neck, axillary lymph node (2 cm), and root
of the mesentery (radiographically a 4 cm lymph node).
On February 24th, 2012, the left supraclavicular lymph
node was surgically excised at Carolina East Medical Cen-
ter. Histologically, the lymph node contained a mixed
population of small and large lymphocytes, plasma cells,
and scattered neutrophils, without evidence of necrosis,
granulomatous inflammation, or abscess formation. There
were no Reed-Sternberg cells indicative of Hodgkin’s disease.
Preliminary pathological diagnosis was lymphadenitis of un-
certain etiology. Fungal, bacterial and mycobacterial cultures
were negative. Immunophenotypic studies, performed at
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protocol, supported a diagnosis of angioimmunoblastic T
cell lymphoma (AILT), with no specific morphologic or
immunophenotpic characteristics to allow subclassifica-
tion. In situ hybridization for Epstein Barr Virus (EBER)
identified scattered positive cells. An addendum report
from The Johns Hopkins Hospital contained the following
statement: “Careful correlation with history is recom-
mended to rule out immunodeficiency. The morphologic
features coupled with a high proliferation rate and numer-
ous mitoses are not seen in typical AILT cases; however,
additional studies and clinical correlation are needed to
exclude this possibility.” March 15th, 2012, the patient was
referred to Duke University Medical Center where the
pathologist concurred with the diagnosis of AILT, how-
ever, the attending lymphoma oncology specialist sug-
gested the possibility of self-limiting lymphadenitis. July
17th, 2012, a pathologist at MD Anderson Medical Center
concurred with the AILT diagnosis. A cervical lymph
node, biopsied July 25th, had effacement of normal nodal
architecture by atypical lymphoid infiltrates, accompanied
by mild vascular endothelial proliferation, and scattered
eosinophils and plasma cells. Angioimmunoblastic fea-
tures were less prominent and features of lymphoma were
more prominent than the previous biopsy. EBER staining
was negative. Immuno-histochemical staining again sup-
ported a diagnosis of AILT. The cancer was PCR positive
for clonal T-cell receptor gamma gene rearrangement and
negative for clonal B-cell immunoglobulin gene rearrange-
ment. ¹ Chemotherapy consisted of oral prednisone and
five cycles of CHOP (cyclophosphamide, doxorubicin, vin-
cristine, prednisone) therapy. Beginning five months after
initiating CHOP chemotherapy, the patient began experi-
encing frequent rigors, night sweats, and was ultimately
diagnosed with FUO, which at various time points was
treated with intravenous and orally administered fluoro-
quinolones, cephalosporins, antivirals, antifungals, intra-
venous dexamethasone and oral prednisone, all of which
failed to induce sustained resolution in the FUO. As de-
scribed for Veterinarian #1, infection with Bartonella hen-
selae can cause FUO [18, 19].
By September 2012, Veterinarian #2 was referred to
MD Anderson Center. He was anemic (HB 8.2 mg/dl,
thrombocytopenic [89,000 platelets/ul]), and had a lym-
phocytosis (12,500/ul). A core bone marrow biopsy con-
tained multiple, atypical, lymphohistiocytic aggregates,
with a prominent epithelioid component. Immunophe-
notyping supported AILT with marrow involvement. In
October 2012, Veterinarian #2 requested Bartonella test-
ing. Because of the historical administration of several
antibiotics, BAPGM enrichment blood culture/PCR was
likely to be diagnostically less sensitive; therefore, paraffin-
embedded lymph node biopsies obtained in February and
July 2012 were tested by conventional PCR. Bartonellahenselae (SA2 genotype) was successfully amplified and
sequenced from the July lymph node specimen. Shortly
thereafter, treatment with doxycycline as the sole therapy
was instituted for bartonellosis and the rigors and fevers
temporarily resolved. In completing the study question-
naire, this veterinarian reported being healthy prior to the
development of lymphadenopathy in February 2012, and
with the exception of FUO accompanied by rigors and
night sweats, CHOP (cyclophosphamide, doxorubicin,
vincristine, prednisone) chemotherapy had been well
tolerated. When the B. henselae lymph node PCR result
became available, I related our experience with doxycyc-
line therapy in experimentally and naturally infected cats
[21], and naturally-infected dogs [22] to the patient’s infec-
tious disease physicians. Doxycycline as a sole antibiotic
would suppress Bartonella sp. bacteremia, but rarely, if
ever, cured the infection. In humans, doxycycline treat-
ments as long as 3 months in duration have resulted in
symptomatic and hematological improvement, but se-
quential blood culture/PCR indicated B. henselae infec-
tions persisted [13, 23].
Due to the progressive nature of the AILT, a decision
was made to treat the patient with allogeneic bone mar-
row stem cell transplantation; however, this therapy was
repeatedly delayed between October 2012 and April 2013
due to recurrent bouts of FUO, which were temporally
followed administration of chemotherapy. B. henselae in-
fection was not detected by BAPGM enrichment blood
culture/PCR [24] in April 2013 (Table 2), shortly before
his death on April 21st, 2013. The planned allogeneic bone
marrow stem cell transplantation was never performed.
In asking the question: “Did B. henselae contribute to
the deaths of these two veterinarians?”; we would first
have to ask, does B. henselae cause FUO and endocardi-
tis? The answer is yes. A second important question is:
“What microbiological evidence supports B. henselae in-
fection?” For Veterinarian #1, B. henselae DNA was ampli-
fied and sequenced from three diagnostic specimens
(bone marrow, blood and mitral valve prosthesis) collected
at three different time points between January 2012 and
February 2013. For Veterinarian #2, B. henselae DNA was
amplified and sequenced from a paraffin-embedded lymph
node obtained surgically, four months prior to PCR testing
in our laboratory. Subsequently, despite ongoing febrile ill-
ness, serology and BAPGM enrichment blood culture test-
ing failed to identify B. henselae DNA or antibodies. As
summarized in a recent review [25], our research labora-
tory has substantial experience with paraffin embedded
tissue PCR [26, 27]. We have also previously described
precautions in processing tissues to avoid DNA carryover
[28]. Our laboratory protocols describe, and we routinely
enforce, rigid work flow patterns to avoid carryover or
DNA contamination with amplified products. Also, nega-
tive DNA extraction, PCR amplification, and BAPGM
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assess Bartonella spp. DNA contamination with every
sample set processed within the laboratory. DNA carry-
over and amplicon contamination are considered an un-
likely source for the microbiological findings in these two
veterinarians. Although isolation is the microbiological
“gold standard” for documenting a bacterial infection,
PCR amplification of organism-specific DNA sequences is
being used to document the presence of fastidious [29],
stealth [1] or “unculturable” bacteria from patient samples
[30]. PCR amplification of organism-specific DNA se-
quences does not confirm that the bacteria is viable or
that the organism is responsible for the patient’s symp-
toms or pathology. However, the molecular microbio-
logical evidence supported B. henselae infection in both
veterinarians.
Another important microbiological question; “Was there
serological evidence to support exposure to B. henselae?”
For reasons that remain unclear, a substantial (50-75 %)
subset of Bartonella spp. bacteremic patients do not have
detectable IFA antibodies [9, 31]. With chronic, asymp-
tomatic or minimally symptomatic Bartonella bacteremia,
a seronegative status may be the norm, rather than the ex-
ception; thus, serology is not a diagnostically or epidemio-
logically sensitive modality. Often after weeks or months
of prior antibiotic therapy, many veterinary workers are
tested for Bartonella infection as an afterthought or as a
“test of last resort.” Using currently available diagnostic
techniques, these bacteria are difficult to enrich, to isolate
or to PCR amplify from tissues under optimal testing con-
ditions. Long delays before obtaining or processing patient
specimens, concurrent or recent antibiotic administration,
and the number of blood or tissue samples tested influ-
ence the sensitivity of the BAPGM enrichment blood cul-
ture/PCR platform. [24, 32] For biopsy specimens, the
tissue sample size, the duration of formalin fixation prior
to paraffin embedding, and the severity and type of inflam-
matory response [26, 27] are important factors that deter-
mine diagnostic PCR sensitivity. Collectively, these factors
influence whether a diagnosis is confirmed or the infection
is missed in a given patient. Timelier collection of optimal
specimens from these two veterinarians may have resulted
in different and diagnostically more beneficial Bartonella
microbiological findings, than we reported above.
Assuming the possibility that both veterinarians were
infected with viable bacteria at the onset of illness and/
or when tested, the next question becomes: “Did the bac-
terium play a role in the initiation or progression of each
patient’s illness?” For Veterinarian #1, the approximate
two-year history of non-specific, waxing and waning
symptoms is consistent with the questionnaire responses
reported by other Bartonella bacteremic veterinary
workers [9–14]. Establishing causation for non-specific
symptoms that accompany infectious and non-infectiousdisease processes is difficult, particularly due to co-
morbidities. However, documenting persistent Bartonella
sp. bacteremia in “non-immunocompromised” individuals
is not impossible, as we have repeatedly demonstrated [9–
14, 23]. Persistent occult blood stream infection may pre-
dispose patients to ongoing microvascular injury, bacterial
localization within various tissues including the vascular
endothelium and heart valves, and the development of
non-specific symptoms. One could hypothesize that Vet-
erinarian #1 progressed from non-specific symptoms to
culture-negative endocarditis, to FUO, to infection of the
mitral valve prosthesis over a three-year timeframe. Cur-
rently, physicians are taught that B. henselae infection in
immunocompetent people is synonymous with cat scratch
disease (CSD), which is considered a self-limiting infec-
tion. Although CSD is most often self-limiting, this does
not appear to be uniformly true [33]. Performing a se-
quential, long-term cohort study of CSD patients in the
United States, as reported from Israel [33], might identify
a subset of persistently B. henselae bacteremic patients
with associated symptomatology and allow for the docu-
mentation of progression of rheumatologic [34] and/or
neurologic disease [15].
A biologically more complex question is: “Did B. hen-
selae infection predispose to the development of lymph-
oma?” Bartonella spp. can invade numerous host cells,
within which the bacteria modify cellular functions by
injecting peptides and potentially transporting bacterial
DNA into the cell [1, 4, 6, 34]. B. henselae contains bac-
teriophages [35] that might also facilitate DNA trans-
location events. Bartonella spp. appear to play causative
or cofactor roles in the development of vasoproliferative
tumors in animals [36] and immunocompetent as well
as immunocompromised people [6]. Comparative stud-
ies of naturally-occurring lymphoma involving animals
and humans are warranted to potentially generate evidence
that supports comparative infectious disease causation
[25]. Although not well studied in human patients, dogs
experimentally-infected with Bartonella vinsonii subsp.
berkhoffii became immunosuppressed [37]. Infection-
induced immune suppression, as suggested by the path-
ologist reviewing the original lymph node biopsy from
Veterinarian #2, has been suggested to occur in associ-
ation with human bartonellosis, caused by B. bacilliformis
[1, 4]. Potentially, DNA translocation events in conjunc-
tion with persistent infection-induced immune suppres-
sion could predispose a patient to develop lymphoma.
Did B. henselae play a role in the deaths of two veteri-
narians? Perhaps yes and perhaps no. For both veterinar-
ians, it seems likely that B. henselae was responsible for
FUO. During their illnesses, and after their respective
deaths, I communicated with both wives. Based upon
their comments during these challenging conversations,
it is their hope that some good may come from their
Breitschwerdt Parasites & Vectors  (2015) 8:317 Page 10 of 11husband’s deaths. Both men were outstanding fathers,
husbands, veterinarians and community servants, each
participating in a large number of volunteer activities.
From my perspective, it is time for a “Bartonella tipping
point,” whereby this emerging pathogen is accorded a
higher national (United States) and international research
priorities.
Endnotes
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Abbreviations
FUO: Fever of unknown origin; EBER: Epstein Barr Virus; AILT: Angioimmunoblastic
T cell lymphoma; CSD: Cat Scratch Disease.
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